Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absent, aforementioned, Albuferon, allege, alleged, alleging, analyzed, appealing, ascending, assumption, award, Bayer, Benefical, Boston, BRIT, budget, Carolina, CED, cediranib, Celldex, cilengitide, complaint, condensed, CT, CTL, daily, decline, deficiency, demostrated, disputed, encompassing, fifteen, GAAP, GCP, gemcitabine, great, guided, Harmonization, ICH, immunocytokine, immunosuppressive, improperly, India, ineffective, infrequent, interfered, interfering, kilogram, led, lessen, load, log, MAb, melanoma, microbubble, mild, missile, MRI, Nexavar, nil, Orange, outsourcing, ovary, peak, peptide, pharmacologic, point, precision, predicated, problematic, proportion, RECIST, recovered, relapse, replase, repurchase, RNA, robust, saving, secret, serum, simplified, slightly, South, stressful, technique, telaprevir, transient, ultrasound, undefined, undergoing, unrecognized, vaccine, valopicitabine, Vectibix, violation, weekly, yield
Removed:
abnormal, allocated, allocation, antidilutive, attendance, attributed, canceled, closely, conversion, converted, create, detachable, earliest, embedded, EMEA, Equiplace, exploring, feature, finder, forced, guidance, implementation, injected, interim, issuable, Medicinal, merged, negotiated, NeoPharm, panitumumab, paper, plc, prominent, quotient, resale, rollforward, SPA, split, tarvacin, transition, TransMID, unamortized, unique, unused, voluntary, Xenova
Filing tables
Filing exhibits
Related press release
CDMO similar filings
Filing view
External links